D. Western Therapeutics Institute (TSE:4576) Inventories, Raw Materials & Components: 円86.92 Mil (As of Dec. 2025)


TSE:4576 D. Western Therapeutics Institute Inc TSE:4576
45 GF Score
Price 円76.00
GF Value 円64.13
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is D. Western Therapeutics Institute Inventories, Raw Materials & Components?

D. Western Therapeutics Institute TSE:4576 +4.11% 45 Inventories, Raw Materials & Components is 円86.92 Mil as of Dec. 2025. GuruFocus rates TSE:4576 with a GF Score™ of 45/100 and a GF Value™ of 円64.13 (Modestly Overvalued). The stock has 3 warning signs investors should review.

D. Western Therapeutics Institute's inventories, raw materials & components for the quarter that ended in Dec. 2025 was 円86.92 Mil.

D. Western Therapeutics Institute's quarterly raw materials declined from Mar. 2025 (円100.63 Mil) to Jun. 2025 (円99.47 Mil) and declined from Jun. 2025 (円99.47 Mil) to Dec. 2025 (円86.92 Mil).

D. Western Therapeutics Institute's annual raw materials increased from Dec. 2023 (円87.86 Mil) to Dec. 2024 (円101.96 Mil) but then declined from Dec. 2024 (円101.96 Mil) to Dec. 2025 (円86.92 Mil).

D. Western Therapeutics Institute Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for D. Western Therapeutics Institute's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute Inventories, Raw Materials & Components Chart

D. Western Therapeutics Institute Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 88.40 79.21 87.86 101.96 86.92

D. Western Therapeutics Institute Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 101.96 100.63 99.47 86.92 131.71
TSE:4576
45GF Score
D. Western Therapeutics Institute Inc TSE:4576
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

D. Western Therapeutics Institute Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of 円86.92 Mil mean?
D. Western Therapeutics Institute (TSE:4576) has a Inventories, Raw Materials & Components of 円86.92 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on D. Western Therapeutics Institute and its competitors.
Is D. Western Therapeutics Institute's Inventories, Raw Materials & Components too high?
D. Western Therapeutics Institute's current Inventories, Raw Materials & Components is 円86.92 Mil. Overall, D. Western Therapeutics Institute has a GF Score™ of 45/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does D. Western Therapeutics Institute's Inventories, Raw Materials & Components compare to VRTX and REGN?
D. Western Therapeutics Institute's Inventories, Raw Materials & Components of 円86.92 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on D. Western Therapeutics Institute and its competitors. D. Western Therapeutics Institute's current Inventories, Raw Materials & Components is 円86.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D. Western Therapeutics Institute stock overvalued right now?
Based on GuruFocus' analysis, D. Western Therapeutics Institute (TSE:4576) is currently considered Modestly Overvalued. The stock's GF Value™ is 円64.13, compared to a current price of 円76.00 — trading 18.5% above its estimated fair value. The current Inventories, Raw Materials & Components is 円86.92 Mil. D. Western Therapeutics Institute's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For D. Western Therapeutics Institute (TSE:4576), the current Inventories, Raw Materials & Components is 円86.92 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D. Western Therapeutics Institute (TSE:4576) Overvalued in 2026?

Based on GuruFocus' analysis, D. Western Therapeutics Institute stock appears to be overvalued. The current stock price of 円76.00 is trading 18.5% above its estimated GF Value™ of 円64.13. GuruFocus considers D. Western Therapeutics Institute to be Modestly Overvalued.

Key valuation signals for TSE:4576:

  • Inventories, Raw Materials & Components: 円86.92 Mil
  • GF Value™: 円64.13 vs. price of 円76.00 (18.5% above fair value)
  • GF Score™: 45/100 with 3 warning signs

No single metric tells the full story. See the TSE:4576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

D. Western Therapeutics Institute Business Description

Other Exchanges 6DW:Germany
Address 7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
45GF Score

Get the complete analysis for TSE:4576

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円76.00
Price
円64.13
GF Value